InVivo Therapeutics Holdings Corp (NVIVQ)

[Devo33]

The stock has been under pressure since announcing the opening of Canada and U.K,, maybe for the reasons you say, or maybe because of the money it will take to do so before revenues begin. With 20 sites enrolled and certified I think the Inspire study will wrap up by summer 2017, a little later than hoped. I believe the delays and lack of enrollment over the last year is due to the desire to tweek the NSS and the procedure so by the 20th implant they have seen all they need to bring the best product to market. Surely the FDA is involved as it is taking so much time. This has increased the uncertainty. Before the first implant and the 4:1 reverse stock split the stock was never below a dollar so I dont see the stock going below $5. Too much progress and success has been achieved. I have a feeling that a couple implants havent been reported yet. The study is going fine. I believe there will be good news soon concerning the study that will move the stock again. Much of the stock movement in the past could have been related to social media. That impact has been reduced. The next announcement will likely report that the 25% FDA performance objective has been met.